Patient Guide: A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 71 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07043725
Status: NOT_YET_RECRUITING
Condition: HER2-positive Breast Cancer
Phase: PHASE3

Where You Can Participate

This study is available at 71 locations across the country.

Top locations include:
  • • Bengbu, Anhui
  • • Hefei, Anhui
  • • Wuhu, Anhui
  • • And 68 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer - Join Clinical Trial NCTNCT07043725

How to Join This Clinical Trial - NCTNCT07043725

Learn how to participate in this PHASE3 trial studying an investigational therapy for HER2-positive Breast Cancer. Current status: NOT_YET_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with HER2-positive Breast Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
HER2-positive Breast Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
NOT_YET_RECRUITING
Study Identifier
NCTNCT07043725 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 71 locations. Find a study site near you:

Clinical Research Site

Bengbu, Anhui 233000 - China

Status: Contact for availability

Clinical Research Site

Hefei, Anhui 230000 - China

Status: Contact for availability

Clinical Research Site

Wuhu, Anhui 241000 - China

Status: Contact for availability

Clinical Research Site

Beijing, Beijing 100005 - China

Status: Contact for availability

Clinical Research Site

Beijing, Beijing 100142 - China

Status: Contact for availability

Clinical Research Site

Chongqing, Chongqing 400010 - China

Status: Contact for availability

Clinical Research Site

Chongqing, Chongqing 400010 - China

Status: Contact for availability

Clinical Research Site

Chongqing, Chongqing 400030 - China

Status: Contact for availability

Clinical Research Site

Chongqing, Chongqing 400038 - China

Status: Contact for availability

Clinical Research Site

Quanzhou, Fujian 362000 - China

Status: Contact for availability

And 61 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for HER2-positive Breast Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships